NCT01468090View on ClinicalTrials.gov

Disease Course in an IBD Cohort in the Era of Biological Treatment

CompletedOBSERVATIONAL

Enrollment

192

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Crohn's DiseaseUlcerative Colitis

Trial Locations (2)

2650

Hvidovre Hospital, Gastroenheden 360, Hvidovre

Hvidovre hospital, Hvidovre

Sponsors

Collaborators (1)

Ferring Pharmaceuticals

All Listed Sponsors

collaborator

Ferring Pharmaceuticals

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Hvidovre University Hospital

OTHER

NCT01468090 - Disease Course in an IBD Cohort in the Era of Biological Treatment | Biotech Hunter | Biotech Hunter